| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |